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40 ABSTRACT
41 Purpose: To describe the care seeking journey and causes of delay among patients with 
42 Microbial Keratitis in Uganda.
43 Methods: A prospective cohort of patients presenting with microbial keratitis at the two main 
44 eye units in Southern Uganda (2016-2018). We collected information on demographics, home 
45 address, clinical history and presentation pathway including:including, order of facilities where 
46 patients went to seek care, treatment advice, cost of care and use of Traditional Eye Medicine. 
47 Presentation time was noted. We compared “direct” presenters versus “indirect” presenters 
48 and analysed predictors of delay.
49 Results: 313 patients were enrolled. All were self-referred. Only 19% of the patients presented 
50 directly to the eye hospital. Majority (52%) visited one facility before presenting, 19% visited 2 
51 facilities, 9% visited 3 facilities and 2% visited 4 facilities. The cost of care increased with 
52 increase in the number of facilities visited. People in a large household, further distance from 
53 the eye hospital and those who used Traditional Eye Medicine were less likely to come directly 
54 to the eye hospital. Visiting another facility prior to the eye hospital and use of Traditional Eye 
55 Medicine aOR 1.58 (95%CI 1.03-2.43), p=0.038 were associated with delayed presentation 
56 to the eye hospital.
57 Conclusion: This study provided information on care seekingpatient journeys to seek care. 
58 Delay was largely attributable to having visited another health facility: a referral mechanism 
59 for microbial keratitis was non-existent. There is need to explore how these gaps health 
60 system gaps can be strengthened.
61 Keywords
62 Microbial Keratitis, Bacterial keratitis, Fungal keratitis, Keratitis, Blindness, Uganda
63
Page 3 of 24
URL: http://mc.manuscriptcentral.com/nope
Ophthalmic Epidemiology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review Only
64 INTRODUCTION
65 Microbial keratitis (MK) can be caused by a range of pathogens, including bacteria, viruses, 
66 protozoa (e.g. acanthamoeba), and fungi (yeasts, moulds and microsporidia). It is 
67 characterised by an acute or sub-acute onset of pain, conjunctival hyperemia and corneal 
68 ulceration with a stromal inflammatory cell infiltrate. MK frequently leads to sight-loss from 
69 dense corneal scarring, or even loss of the eye, especially when the infection is severe and/or 
70 appropriate treatment is delayed.1 MK is important because it is a leading causes of uniocular 
71 blindness worldwide.2,3 
72 In Sub Saharan Africa, the incidence of MK has been suggested to be around 
73 180/100,000/year.4 Bacterial (staphylococcus, streptococcus and pseudomonas) and fungal 
74 (fusarium and aspergillus) are the most common with an almost 50:50 proportion.5-11
75 In Lower and Middle-Income Countries (LMIC), MK management is often more challenging 
76 because of late presentation, use of Traditional Eye Medicine (TEM), insufficient diagnostic 
77 support, lack of effective drugs and keratoplasty services.11,12
78 A critical step in effectively managing MK is ensuring that patients start appropriate treatment 
79 as early as possible. This is because once the infection is well established, there is little that 
80 can be done to change its course.13 It is believed that many MK start following corneal 
81 abrasions. Studies in Burma and Bhutan showed that if people with a simple corneal abrasion 
82 applied antibacterial or antifungal medication responded within the first 24-48 hours, to a 
83 simple corneal abrasion by applying antibacterial or antifungal medication, there was full 
84 recovery without any infectious sequalae.14-16
85 Delayed presentation of patients is a key determinant of outcomes.12 Patients typically present 
86 at least two weeks after the onset of the first symptoms.12 There are a number of factors that 
87 could contribute to this delay such as: distance from the hospital, transportation costs, poverty, 
88 self-medication and tortuous referral pathways through the health system.17-19 Prior visit to a 
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89 non-specialist health facility has been implicated as a cause of delay in other eye 
90 conditions.18,20
91 In Uganda, the public health system has six levels, with the lowest point of care being at the 
92 village level (Village Health Committee).21 However, physically, a Health Centre II (HC II) is 
93 the lowest unit and is located at a parish level, HC III at sub-county level, HC IV at county 
94 level, district hospital (HC V), and referral hospital (HC VI). These units have quite different 
95 staffing and capacity in terms of service provision. There are several different levels of private 
96 health care providers as well. Patients are referred up this tier system depending on the 
97 complexity of their condition. 
98 Therefore, to investigate the role of the health system in providing care and onward referral of 
99 people with MK, here we describe the presentation pathway and factors associated with 
100 delayed presentation, among patients with microbial keratitis in Uganda.
101 METHODS
102 Ethical statement
103 This study followed the tenets of the Declaration of Helsinki. It was approved by the London 
104 School of Hygiene & Tropical Medicine Ethics Committee (Ref 10647), Mbarara University 
105 Research Ethics Committee (Ref 10/04-16) and Uganda National Council for Science and 
106 Technology (Ref HS-2303). Written informed consent in “Runyankore” the local language was 
107 obtained before enrolment. If the participant was unable to read, the information was read to 
108 them any by the research assistant. The participant was theny were asked to place a 
109 thumbprint on the consent form , which was independently witnessed.
110 Study design and setting
111 This was part of a study where we prospectively enrolled patients with MK that presented to 
112 Ruharo Eye Centre (REC) and Mbarara University and Referral Hospital Eye Centre 
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113 (MURHEC) from December 2016 to March 2018. MURHEC is a government owned tertiary 
114 eye unit established in 2013. It provides mostly free services and sees about 6,000 - 10,000 
115 patients/year. REC is a church-based, fee-paying tertiary eye hospital founded in the 1960s. 
116 It sees about 20,000 - 25,000 patients/year. Both hospitals are in Mbarara Municipality, South-
117 Western Region, Uganda, approximately four hours’ drive from Kampala. The two units are 
118 about 5km apart and work closely together.
119 Participants
120 All patients that were enrolled into the cohort study were included. In that cohort study, we 
121 aimed to recruit all MK cases presenting during a year in order to have a powerful sample set 
122 to answer detailed questions around the seasonal microbiological patterns. It was important 
123 to recruit for a full year as MK had been shown in other parts of the world to have seasonal 
124 variations in its’ epidemiology.22
125 Study participants
126 The inclusion criteria for the bigger prospective study was the presence of acute MK at 
127 presentation to the hospital defined as EITHER (i) corneal epithelial ulceration (1mm 
128 diameter) AND corneal stromal infiltrate AND evidence of acute ocular inflammation (e.g. 
129 Conjunctival injection / anterior chamber inflammatory cells / hypopyon); OR (ii) a corneal 
130 abscess (1mm diameter) AND evidence of acute ocular inflammation. We excluded those 
131 not willing to participate, those not willing to return for follow-up, pregnant women, lactating 
132 mothers, those aged below 18 years.
133 Data collection procedures
134 Patients presenting with MK were introduced to the study and the informed consent processes 
135 followed. They were assigned a unique study number and their age, sex, occupation and place 
136 of residence recorded. A history was taken of the circumstances in which their eye became 
137 infected, the predisposing factors (such as trauma and use of Traditional Eye Medicine [TEM]). 
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138 A meticulous “journey” history was taken to document the date when they developed 
139 symptoms, where and when they sought treatment (name and level of the health centre), what 
140 medical advice and treatment was given (including whether they were referred to the eye 
141 hospital or not), how much each step cost them in Uganda shillings (transportation, 
142 consultation fees, medicines). The total amount of money recorded was for all the costs 
143 incurred before patients were enrolled into the study.
144 The place where they first received any form of treatment was denoted as “Facility 1”, the 
145 second place visited (either as a result of formal referral or self-initiated referral) was denoted 
146 “Facility 2” and so on. GPS coordinates were generated for the patients’ addresses (to the 
147 nearest village, parish, county school or health centre-depending on what was available on 
148 Google maps). Presenting Log MAR (Logarithm of Minimum Angle of Resolution) visual acuity 
149 at 2 metres in a dark room was measured using Peek Acuity software.23 For visual acuities of 
150 counting fingers or less, Log MAR values were attributed as follows: counting fingers, 2.0; 
151 hand movements, 2.5; perception of light, 3.0; and no perception of light, 4.0.24 The patients 
152 were then examined on a slit lamp and clinical signs carefully recorded. Infiltrate size was 
153 measured as the greatest diameter of the infiltrate (dimension 1) and the diameter of an 
154 imaginary line perpendicular to the widest axis (dimension 2). The final infiltrate size was then 
155 derived as the geometrical mean of the two diameters.25 The same was repeated after 
156 fluorescein staining of the ulcer to measure the epithelial defect sizes. Corneal specimens 
157 were obtained for microbiological testing at Mbarara University Microbiology Department. 
158 Patients were treated as per the hospital treatment protocol and followed up periodically for 
159 up to 3 months to determine their outcome. 
160 Analysis
161 Data were analysed in STATA v14. “direct” presenters were defined as participants whose 
162 first point of care was the eye hospital (MURHEC or REC). “Indirect” presenters are those who 
163 first went to other health centres before presenting to the eye hospital. Summary frequency 
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164 tables of demographics and clinical presentation of “direct” versus “indirect” presenters were 
165 generated with appropriate statistical tests for each variable (Wilcoxon rank sum for the 
166 continuous variables and 2 test for the categorical variables). To determine where the 
167 participants came from, Google maps was used to pinpoint to the addresses of the 
168 participants. The presentation journey was described using interval times in days from home 
169 to Facility 1 or from Facility 1 to Facility 2 and so on (presented as median time in days with 
170 Inter Quartile Ranges [IQRs]). To describe the cost of care, the total patient expenditure at 
171 different facilities were summarised and cumulative expenditure derived depending on how 
172 many facilities an individual visited. Costs are presented as median expenditure in Uganda 
173 shillings with IQRs.
174 Presentation time was defined as the time in days it took a patient to come to the eye hospital 
175 after onset of symptoms. For analysis of delay, presentation time was divided into quartiles as 
176 “early” (0-7days), “intermediate” (8-14days), “late “(15-30days) and “very late” (>30days). 
177 Ordinal logistic regression was performed to determine the factors associated with these four 
178 quartiles of “delay”, while logistic regression was performed to determine factors associated 
179 with direct presentation. Univariable regression was performed to generate crude Odds Ratios 
180 (OR). After assessing for collinearity, variables with a p-value less than 0.1 were introduced 
181 in the multivariable model. A backward stepwise approach was then used, until only the 
182 variables with a p-value <0.05 were retained. Adjusted OR were reported for the final model.
183 RESULTS
184 Demographic features
185 During the study period, 313 patients were enrolled into this study. The baseline 
186 characteristics of direct versus direct presenters are shown in Table 1. Overall, the direct and 
187 indirect presenters were similar for many variables. However, the direct presenters lived closer 
188 to the eye hospital (median 58km vs. 87km; p=0.0001), had fewer household members 
189 (median 5 people vs. 7 people; p=0.006) and fewer were farmers (59% vs. 73%, p=0.031).
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190 Table 2 shows some select clinical history and signs of direct versus indirect presenters. 
191 Compared to indirect presenters, direct presenters had a shorter presentation time (median 8 
192 days vs. 17 days; p<0.0001), had slightly better presenting vision (median Log MAR 0.65 vs. 
193 1.3; p=0.075), a smaller infiltrate size (median 4.2 mm vs. 5.5 mm; p=0.025) and a smaller 
194 epithelial defect (median 3.5 mm vs. 4.1 mm; p=0.048). The proportion of people who had 
195 used TEM was higher among the indirect (63%) versus direct presenters (46%), p=0.020. The 
196 direct and indirect presenters had similar proportions with a history of trauma, hypopyon, an 
197 opaque stromal opacity and perforation.
198 Factors associated with direct presentation
199 On univariable and multivariable analysis summarised in Table 3. People who lived far from 
200 the eye hospital (overall p=0.003), those from large households OR 0.53 (95%CI 0.32-0.85), 
201 p=0.0080 and those who had used TEM OR 0.48 (95% CI 0.25-0.90), p=0.020 were less likely 
202 to be direct presenters.
203 Care seeking pathway
204 Figure 1 shows where the patients came from in relation to the eye hospital (MURHEC or 
205 REC). Most came from the South Western region of Uganda and a handful from Northern 
206 Tanzania. Figure 2 shows the place where patients were first treated. Majority (46%) sought 
207 treatment at a nearby clinic/pharmacy/drug-shop, 19% presented directly to the eye hospital, 
208 15% were initially treated at home (either used TEM or an old eye drop) and 17% were treated 
209 at various levels of the health system (HC II, HC III, HC IV and district hospital). Some patients 
210 (2%) did not know the type of facility where they first sought care and only 1% went to a 
211 traditional healer’s shrine for treatment.
212 Figure 3 illustrates the pathway patients took to come to the eye hospital and the different 
213 times spent on each stage. Only 55 (20%) patients presented directly to the eye hospital, 
214 majority (134, 51%) visited one facility before presenting to the eye hospital, another 43 (19%) 
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215 visited two facilities, 24 (9%) visited three facilities and 5 (2%) visited four facilities. On 
216 average, patients took about a week to move from one facility to the next. The shortest 
217 response time was from onset of symptoms to Facility 1 and was even shorter among indirect 
218 presenters, median 2 days (IQR 0-5) versus direct presenters, median 8 (IQR 2-18), 
219 P<0.0001. The longest interval time was from Facility 4 to the eye hospital, median 13 (IQR 
220 10-33). The choice of the first facility did not affect overall presentation time. All the patients 
221 were self-referred.
222 We found in our study that most patients used TEM after having been to a health facility 
223 (secondary use). Out of the 188 who used TEM, only 51 used TEM as primary treatment (47 
224 at home and 4 at the traditional healers’ shrine). The rest (137/188) had secondary TEM 
225 application.
226 Cost of care
227 The cost of care in Uganda shillings (UGX) is presented in Table 4. The cost of care increased 
228 with increase in the number of facilities visited. There was evidence (Cuzick test for trend 
229 p<0.0001), of an association between expenditure and number of facilities visited prior to 
230 presentation. The lowest spend was for direct presenters where the median expenditure was 
231 UGX 30,000 (IQR 7,000-63,000, total range 0-385,000) and the largest spend was among 
232 patients who had visited 4 facilities before presentation with a median expenditure of UGX 
233 284,000 (IQR 118,000-439,500, total range 96,000-864,000). Across the different expenditure 
234 lines, medicines were the most expensive followed by transportation, consultation fees were 
235 the least expensive.
236 Factors associated with delay
237 We tested for associations with delay in presenting to the eye hospital, (Table 5). After 
238 adjusting for distance, visiting another facility prior to the eye hospital was strongly associated 
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239 with delay but no obvious trend. Previous use of TEM was also found to be associated with 
240 delay OR 1.58 (IQR 1.03-2.43), p=0.038
241 DISCUSSION
242 This study aimed to describe the presentation journey and factors associated with delay. 
243 Factors associated with delay were having visited another health facility and prior use of 
244 Traditional Eye Medicine (TEM). This supported our hypothesis that an initial visit to a health 
245 facility introduced delay as had been reported previously for other eye conditions.18,20,26 After 
246 onset of symptoms, the majority of patients quickly visited a health facility to seek treatment. 
247 This was an impressive median response time (within 48 hours). Although we did not explicitly 
248 ask their reasons for presenting early to these facilities, the painful nature of MK, proximity of 
249 the facilities and trauma (for those who had it) could have played a role. Perhaps, if appropriate 
250 treatment had been given or rapid referral made at this stage, the outcomes might have been 
251 better.13,14,16
252 At the first point of contact with the health system, there were three missed opportunities that 
253 we identified in our study, these were: to promptly initiate appropriate treatment; to triage and 
254 urgently refer; and health education advice against TEM use. We discuss these below.
255 Firstly, the health facility where most patients presented first were usually a nearby pharmacy 
256 /clinic. These are mostly private clinics that have sprouted up in many parts of Uganda. They 
257 are loosely regulated, manned by primary health workers and do not require a doctor’s 
258 prescription to dispense treatment. Effective anti-microbial medication such as Natamycin and 
259 Ciprofloxacin eye drops are not available in such units. These could be potential stakeholders 
260 to target in promotion of triage and referral mechanisms for MK. We found that there was no 
261 referral mechanism for MK: all patients who came to the eye hospital were self-referred.
262 Secondly, all the patients who visited a health facility we given some treatment but none of 
263 the patients was ever referred for specialist care. Most of the health centres (II and III) are 
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264 managed by mid-level cadres, who may not have the necessary skills and tools to appreciate 
265 the urgency and seriousness of MK. General eye health training has been previously reported 
266 to be limited among mid-level cadres in the region.27 In addition, Uganda is still grappling with 
267 a major shortage of human resources for eye health. An eye specialist is found at some level 
268 six facilities and a mid-level ophthalmic cadre might be available in some level IV onwards.28 
269 We plan to conduct a study into factors around the health system that could be developed to 
270 strengthen treatment, triage and referral.
271 Thirdly, we found in our study that most patients used TEM after having been to a health facility 
272 (secondary use). This is worrying because these were patients who could have been 
273 sensitised against TEM use at the health facilities where they first presented. This was a 
274 missed opportunity that needs to be addressed.
275 Fifty-Eight (19%) of the patients were direct presenters. As expected, people who had large 
276 households, those who lived far from the eye hospital and those who used TEM were less 
277 likely to present directly to the eye hospital. Understandably, use of TEM and having a large 
278 household were negative predictors for being a dir ct presenter. Most of the people who used 
279 TEM used it at home and this was marked as a treatment event in our study design. Many 
280 patients in our cohort were heads of households and the sole bread winners, they might have 
281 preferred to first seek treatment at a place near home.
282 The cost of care was variable depending on the number of facilities visited. Most of the money 
283 was spent on drugs, and transportation. The public health system in Uganda is largely free or 
284 highly subsided. Expenses are incurred on transportation and sometimes medicines when 
285 they are out of stock. For the case of MK, drugs such as Natamycin have only been erratically 
286 and expensively supplied by select private pharmacies and not available in the public health 
287 system. We anticipate this to change as Natamycin was recently added on the WHO essential 
288 medicines list.29
289 Strengths/limitations
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290 This study was the first in SSA to systematically collect information on how MK patients seek 
291 care and what influences their pattern. It provides useful information on key health system 
292 gaps that need strengthening. Before this study, it had been thought that patients had poor 
293 health seeking behaviour, however, what we found was that majority of people presented to a 
294 health facility quite early after the onset of symptoms. Secondly, although TEM use was a 
295 known problem, this study showed that the bigger problem was secondary TEM use, that is 
296 patients who opted to use TEM even after they had been to a health facility.
297 Although we collected information on distance covered and treatment given at each level, it 
298 was difficult to analyse for these because most patients did not come to the eye hospital with 
299 their medicine and could not recall the names. There were many circular movements that 
300 made it complicated to analyse total distance covered by each patient. A qualitative approach 
301 in discussing with patients what informed their choice of self-referral or direct presentation 
302 would have strengthened the evidence in this study.
303 CONCLUSION
304 Delayed presentation to a specialist eye hospital is a problem in the care of MK, and that this 
305 appears to be largely attributable to slow referral through the health system. There are 
306 opportunities for health education, early referral, appropriate treatment and sensitization 
307 against TEM use that could be utilized to improve care of MK.This important insight highlights 
308 the missed opportunities in the health system that need to be addressed to improve a triage 
309 and referral mechanism for MK, prompt appropriate treatment and sensitisation against TEM 
310 use. More needs to be done to understand what goes on in the health system and how this 
311 can be strengthened.
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Table 1: Baseline characteristics of direct versus indirect presenters (n=313)
Direct presenters (n=58) Indirect presenters (n=255) P-value
Variable Median (IQR) (Total 
range)
Median (IQR) (Total 
range)
Age 47 (35-60) (18-96) 47 (35-60) (18-87) 0.772
Distance to Eye Units 58 (16-85) (0.2-244) 87 (57-131) (2-378) 0.0001
Household population 5 (3-7) (1-14) 7 (4-8) (1-28) 0.006
Distance to nearest Health Centre in Km* 2 (1-3) (0-14) 3 (1-4) (0-45) 0.174
Variable Cat gory count (%) count (%) P value 
Gender Female 22 (38%) 117 (46%) 0.271
Male 36 (62%) 138 (54%)
Occupation Farmer 34 (59%) 186 (73%) 0.031
Non-farmer 24 (41%) 69 (27%)
Marital status Unmarried Ɨ 18 (31%) 77 (30%) 0.900
Married 40 (69%) 178 (70%)
Education status None 15 (26%) 69 (27%) 0.407
Primary 29 (50%) 133 (52%)
Secondary 7 (12%) 38 (15%)
Tertiary 7 (12%) 15 (6%)
Being head of household Yes 42 (72%) 170 (67%) 0.398
No 16 (28%) 85 (33%)
Needed an escort to hospital* Yes 24 (41%) 49 (20) <0.0001
No 34 (59%) 202 (80)
*Variables with some missing data: distance to nearest health centre was measured in km (n=312, [direct 57]) needed an escort (n=309, [direct 
58]). Ɨ Unmarried included single, divorced and widowed,
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Table 2: Clinical history and clinical signs of direct versus indirect presenters (n=313)
Direct presenters (n=58) Indirect presenters (n=255) P value
Variable Median (IQR) (Total 
range)
Median (IQR) (Total 
range)
Presentation time in days* 8 (2-18) (0-116) 17 (8-32) (0-370) <0.0001
Presenting Vision (Log MAR) 0.65 (0.1-2.5) (0-4) 1.3 (0.3-2.5) (0-4) 0.072
Infiltrate size in mm Ɨ* 4.2 (2.5-7.1) (0.9-11) 5.5 (3.5-8) (0.5-13) 0.025
Epithelial defect size in mm Ɨ* 3.5 (1.8-5.8) (0-11) 4.1 (2.5-6.9) (0-13) 0.048
Variable Category count (%) count (%) P value 
History of trauma (overall 29%) ǂƚ Yes 14 (25%) 77 (30) 0.388
No 43 (75) 177 (70)
Used Traditional Eye Medicine (overall 61%) Yes 27 (46) 161 (63) 0.020
No 31 (53) 94 (37)
Pain being the main complaint Yes 26 (45%) 112 44 0.121
No 32 55 143 56
Opaque stromal opacity ǂƚ Yes 25 (43) 107 (44) 0.918
No 33 (57) 137 (56)
Hypopyon ǂƗ Yes 13 (22) 81 (32) 0.151
No 45 (78) 172 (68)
Perforated at admission Yes 10 (17) 66 (26) 0.166
No 48 (83) 189 (74)
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* Presentation time was measured as duration in days it took to come to the eye hospital after onset of symptoms. Ɨ geometrical of the largest 
diameter and the diameter perpendicular to the largest diameter. ǂƗ variables that had less than 313 observations due to missing data (trauma 
n=311 [direct57] , opaque stromal opacity n=302 [direct 58], hypopyon n=311 [direct 58]).  
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Figure 1 A map of Uganda showing patients homes
Each point represents a patient. The red circle is the eye hospital where these patients 
presented.
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Figure 2 showing where patients first accessed treatment (n=309)
Key: Clinic refers to clinic/pharmacy/drug shop, District is district hospital, MURHEC is the main 
eye hospital (Mbarara University and Referral Hospital Eye Centre and Ruharo Eye Centre)
Page 20 of 24
URL: http://mc.manuscriptcentral.com/nope
Ophthalmic Epidemiology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review Only
Table 3: Univariable and multivariable logistic regression analysis of factors associated with direct presentation to the eye hospital (n=309)
Univariable analysis Multivariable analysis
Variable cOR (95% CI) p-value aOR (95% CI) p-value
Age in years 1.004 (0.987-1.022) 0.576
Sex (being male) 1.38 (0.77-2.48) 0.273
Marital status (being married) 0.96 (0.52-1.78) 0.900
Occupation (being a farmer) 0.52 (0.29-0.94) 0.033
Being head of household 1.31 (0.69-2.46) 0.399
Number of people in household (increase/one person) 0.59 (0.38-0.90) 0.015 0.53 (0.32-0.85) 0.008
Distance to the eye hospital
0-50km 1 0.001 0.003
50-100km 0.52 (0.26-1.01) 0.62 (0.30-1.27)
100-150km 0.16 (0.05-0.44) 0.16 (0.06-0.48)
>150km 0.42 (0.17-1.03) 0.52 (0.19-1.34)
Distance from nearest health centre (increase per 1km) 0.92 (0.822-1.029) 0.146
Positive history of trauma 0.74 (0.38-1.44) 0.389
Positive history of TEM Use 0.50 (0.28-0.90) 0.021 0.48 (0.25-0.90) 0.020
Education status
None 1 0.462
Primary 1.00 (0.50-1.99)
Secondary 0.84 (0.31-2.25)
Tertiary 2.14 (0.74-6.17)
*patients with missing data were dropped from the model. OR less than 1 means they were less likely to come directly to the eye hospital
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Figure 3: The care seeking journey of patients with Microbial keratitis and the time taken at 
each step (n=276)
In this analysis, only patients with complete data were included.  START refers to when the 
symptoms started. Facility refers to a health centre or clinic/pharmacy and not necessarily 
the hierarchy of the health centres
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Table 4: Money spent by patients per number of facilities visited before coming to the eye hospital
Cost of Care Median (IQR) in Uganda Shillings*
Facility n (%) Transportation Consultation Medicine Total expenditure
0 58 (18.5%) 11,000 (4,000-20,000) 15,000 (0-15,000) 0 (0-27,000) 30,000 (7,000-63,000)
1 147 (52%) 19,500 (10,000-33,000) 15,000 (15,000-15,000) 19,800 (2,750-99,500) 52,000 (31,000-142,000)
2 58 (18.5%) 22,000 (15,000-37,000) 15,000 (0-15,000) 25,750 (6,000-80,000) 67,750 (34,250-142,500)
3 29 (9%) 30,000 (19,000-51,000) 15,000 (0-15,000) 28,500 (3,000-70,000) 78,250 (32,000-209,000)
4 6 (2%) 62,500 (33,000-143,000) 12,500 (10,000-30,000) 170,500 (78,000-343,500) 284,000 (118,000-
439,500)
P value of test for trend <0.0001
*All money is quoted in Uganda shillings. The US $ exchange rate was US $1: Uganda shillings 3,700 (2017). Ɨ0-direct presenters who did not 
visit any other facility before coming to the eye hospital. Patients with incomplete data were not included in this analysis
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Table 5: Univariable and multivariable ordinal logistic regression analysis of factors associated with delay among patients with Microbial 
Keratitis (n=309)
Univariable analysis Multivariable analysis
Variable cOR (95% CI) p-value aOR (95% CI) p-value
Age in years 1.009 (0.994-1.019) 0.140
Sex (being male) 1.06 (0.71-1.58) 0.792
Marital status (being married) 0.86 (0.55-1.33) 0.316
Occupation (being a farmer) 1.24 (0.80-1.93) 0.339
Being head of household 0.83 (0.54-1.27) 0.394
Number of people in household (increase/one 
person)
1.14 (0.85-1.51) 0.365
Distance to the eye hospital (every 10km increase) 1.036 (1.003-1.) 0.034
Distance from nearest health centre (increase per 
1km)
1.01 (0.97-1.06) 0.501
Positive history of trauma 0.96 (0.62-1.49) 0.860
Positive history of TEM Use 1.73 (1.14-2.62) 0.010 1.58 (1.03-2.43) 0.038
Other facilities visited before eye hospital 
Nil (direct presenters) 1 0.0002 1 0.001
One facility 2.95 (1.63-5.38) 2.74 (1.53-4.92)
Two facilities 3.62 (1.74-7.52) 2.58 (1.30-5.15)
Three facilities 4.12 (1.82-9.34) 3.26 (1.42-7.45)
Four facilities* 15.5 (2.65-90) 14.3 (2.45-83.7)
*2 patients had visited 5 facilities and one patient 6 facilities, these were dropped from the analysis
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